A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy and Safety of NNC0114-0006 in Subjects With Active Crohn's Disease
Clinical trial NCT01751152 · COMPLETED
Trial details
- NCT number
- NCT01751152
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2014-12-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.